{"id":"NCT02161757","sponsor":"AstraZeneca","briefTitle":"A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma","officialTitle":"A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting β2-Agonist.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-06-13","primaryCompletion":"2017-02-28","completion":"2017-07-18","firstPosted":"2014-06-12","resultsPosted":"2018-04-17","lastUpdate":"2018-08-28"},"enrollment":1207,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Uncontrolled Asthma"],"interventions":[{"type":"BIOLOGICAL","name":"Tralokinumab","otherNames":[]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Tralokinumab Dose Regimen 1","type":"EXPERIMENTAL"},{"label":"Placebo Dose Regimen 1","type":"PLACEBO_COMPARATOR"},{"label":"Tralokinumab Dose Regimen 2","type":"EXPERIMENTAL"},{"label":"Placebo Dose Regimen 2","type":"PLACEBO_COMPARATOR"}],"summary":"A 52-Week, Multicentre, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents with Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting β2-Agonist","primaryOutcome":{"measure":"Annualised Asthma Exacerbation Rate (AAER) up to Week 52","timeFrame":"Baseline (Week 0) up to Week 52","effectByArm":[{"arm":"Tralo 300 mg Q2W","deltaMin":0.56,"sd":null},{"arm":"Tralo 300 mg Q4W","deltaMin":0.54,"sd":null},{"arm":"Placebo","deltaMin":0.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.5859"},{"comp":"OG001 vs OG002","p":"0.4406"},{"comp":"OG000 vs OG002","p":"0.5859"},{"comp":"OG001 vs OG002","p":"0.4406"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":243,"countries":["United States","Argentina","Belgium","Bulgaria","Colombia","Germany","Hungary","Peru","Poland","Slovakia","South Korea","Spain","Taiwan","Ukraine","Vietnam"]},"refs":{"pmids":["31315668","30649752","29792288","29536781"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":40,"n":398},"commonTop":["Viral upper respiratory tract infection","Upper respiratory tract infection","Asthma","Headache","Bronchitis"]}}